Nasdaq - After-hours US$ 4.03 = AU 54c.....
Same old traders story I'm afraid. 'Buy the rumour - sell the fact'.
Its frustrating to watch - even for an IMM old timer like me. For a biotech in late stage trials (multiple P2 trials and about to embark on P3 after successful data) our market cap - $500m is woeful. Why is this? $100m in the bank too.
Several other ASX biotechs in the oncology space, at a much earlier clinical stage have a significantly higher MC.
It could be that Lag-3 and efti has taken a very long time to get to this stage of its clinical development and interest is in other up and coming novel treatments?
TBH - I've given up realising any reasonable/significant gain until Big Pharma put their hand in their pocket - if that ever happens of course! Competitive tension has a limit before the elastic snaps....
Totally p'd off - apologies.....
- Forums
- ASX - By Stock
- IMM
- Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-28
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
41.8¢ |
Change
-0.003(0.60%) |
Mkt cap ! $594.7M |
Open | High | Low | Value | Volume |
41.5¢ | 42.0¢ | 41.0¢ | $428.6K | 1.038M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 136624 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 122459 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 134452 | 0.415 |
10 | 331001 | 0.410 |
9 | 76797 | 0.405 |
13 | 131219 | 0.400 |
10 | 560333 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 122459 | 13 |
0.425 | 302468 | 10 |
0.430 | 128737 | 8 |
0.435 | 144668 | 6 |
0.440 | 75936 | 6 |
Last trade - 14.09pm 25/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |